Drug Executive Collapses During Oval Office Event
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump announced a deal with drugmakers to reduce obesity drug prices. The event was interrupted when the executive collapsed.
Details of the Incident
The man who fainted was identified as Gordon Findlay, the global brand director for Novo Nordisk. The incident occurred while David Ricks, CEO of Eli Lilly, was giving remarks about the agreement involving Eli Lilly and Novo Nordisk to expand coverage and lower prices for their obesity treatments, Zepbound and Wegovy.
Response and Immediate Actions
As Gordon Findlay fell to his knees, Dr. Mehmet Oz quickly intervened to assist him. The press was then asked to leave, and the event was paused.
David Ricks said, "Are you okay? Gordon, are you okay?"
Health and Human Services Secretary was also present during the incident.
Updates After the Incident
About 30 minutes later, the press conference resumed, and President Trump provided an update on Findlay's health.
President Trump commented on the situation, reassuring attendees about the executive’s condition.
Summary
A drug executive fainted during a press event in the Oval Office, prompting quick medical assistance and a temporary halt to the conference, with the President later giving a health update.
Author’s Summary
The unexpected collapse of a drug executive highlighted the tense atmosphere during a major announcement on lowering obesity drug prices in the Oval Office.